Scholar Rock Holding Corporation (SRRK) Discusses FDA Approval and Clinical Impact of ISEMBYLD in SMA Treatment September 14, 2026 8:00 AM EDT
Company Participants
Laura Ekas – Vice President of Investor Relations
David Hallal – CEO & Chairman of the Board
Akshay Vaishnaw – President of R&D, Member of Scientific Advisory Board and Director
Robert Keith Woods – Chief Operating Officer
Vikas Sinha – CFO & Treasurer
Conference Call Participants
Eric Schmidt – Cantor Fitzgerald & Co., Research Division
Michael Yee – UBS Investment Bank, Research Division
Srikripa Devarakonda – Truist Securities, Inc., Research Division
Cory Kasimov – Evercore ISI Institutional Equities, Research Division
Jarwei Fang – Citigroup Inc. Exchange Research
Tessa Romero – JPMorgan Chase & Co, Research Division
Evan Seigerman – BMO Capital Markets Equity Research
Allison Bratzel – Piper Sandler & Co., Research Division
Gary Nachman – Canaccord Genuity Corp., Research Division
Ritu Baral – TD Cowen, Research Division
Basma Radwan Ibrahim – Leerink Partners LLC, Research Division
Presentation
Operator
Good morning, ladies and gentlemen, and welcome to Scholar Rock’s call to discuss the U.S. approval of ISEMBYLD. [Operator Instructions] This call is being recorded today on Monday, September 14, 2026. I would now like to turn the conference over to Scholar Rock team. Please go ahead.
Laura Ekas
Vice President of Investor Relations
Good morning. I’m Laurie Ekas, Vice President, Investor Relations at Scholar Rock. With me today are David Hallal, Chairman and Chief Executive Officer; Akshay Vaishnaw, President of R&D; Keith Woods, Chief Operating Officer; and Vikas Sinha, Chief Financial Officer.
Before we begin, I’d like to remind you that during this call, we will be making various statements about Scholar Rock’s expectations, plans and prospects that constitute forward-looking statements for the purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Any forward-looking statements represent our views only as of today and should not be
You must be logged in to post a comment Login